Start
•Completion
Low Dose Ketamine Infusion for the Treatment of Resistant Depression
WithdrawnRegisteredCTG
Observational prospective cohort collecting outcomes after low-dose IV ketamine infusions for treatment-resistant depression in admitted adult patients.
Details
Prospective descriptive study extracting electronic health record data on adults with treatment-resistant depression who receive physician-ordered ketamine infusions in hospital settings; assessments include QIDS pre and 24 hours post infusion and vital signs monitoring.
Ketamine is administered IV in 50 mL normal saline at either 0.5 mg/kg over 40 minutes or 1 mg/kg over 90 minutes per ICU attending decision; monitoring includes vitals every 15 minutes during infusion and until recovery.
Topics:Treatment-Resistant Depression (TRD)
Registry
Registry linkNCT04283058